Webinar Registration

ADMET Predictor® 14: expanded bRo5, HTPK, and AI capabilities

Drug discovery is maturing. Researchers are increasingly focusing on challenging targets, including beyond Rule of 5 (bRo5) compounds, to achieve previously intractable therapeutic opportunities. Simultaneously, they’re under growing pressure to make reliable ADMET predictions in chemical spaces where many conventional models perform poorly.

This evolution requires predictive modeling platforms that can keep up.

Join us for our next webinar to learn what ADMET Predictor® 14 enables you to do. Dr. Jeremy Jones, Principal Scientist, and Dr. David Miller, Engineering Fellow, will describe several newly added predictive models, the updating of existing models to better cover bRo5 space, and key improvements to the high-throughput pharmacokinetic (HTPK) simulation module, command line and REST API, in addition to a new command-line version of ADMET Modeler.

They will also provide a preview of the new Simulations Plus AI-enabled platform that seamlessly combines a natural-language prompt interface with our powerful ADMET Predictor engine.

Wednesday, September 16, 2026
8:00 AM PDT | 11:00 AM EDT | 5:00 PM CEST

Speakers

Dr. Jeremy Jones

Principal Scientist
Simulations Plus

Jeremy joined Simulations Plus in November 2022 as a Principal Scientist focused on early stage drug development and AIDD. Prior to joining the company, Jeremy was the Director of Oncology at Terray Therapeutics and led his own consulting company. Before that, he was a Professor at City of Hope Comprehensive Cancer Center for nearly a decade where his lab focused on drug development and translational research in urologic oncology.

Jeremy received his Ph.D. in Microbiology and Immunology from Stanford University and completed his postdoctoral fellowship at the University of California, San Francisco. He now resides on the North Shore of Auckland, New Zealand, where he enjoys time at the beach with his family.

Dr. David Miller

Engineering Fellow
Simulations Plus

David is an Engineering Fellow at Simulations Plus. He previously worked at Sage Informatics, a small cheminformatics software startup he founded in 2001 and that Simulations Plus acquired in 2005, as well as at Bioreason and CombiChem. He received his Ph.D. in Biophysics from the University of California at San Francisco.

David is one of the lead software engineers for the ADMET Predictor software platform, where his primary responsibilities are the core chemistry engine and graphical user interface. He makes numerous presentations on ADMET Predictor at customer sites in the United States and abroad.

Tom Sanderson

Business Development Director (Moderator)
Simulations Plus

Tom joined Simulations Plus in April 2025 as Business Development Director with a focus to support the commercial growth of the ADMET Predictor® software platform given his background in Cheminformatics software sales.

Tom completed his undergraduate studies in Chemistry at the University of Nottingham, UK and PhD at the University of York, UK in medicinal chemistry. He then spent four years practicing as a synthetic medicinal chemist at Concept Life Sciences, where he supported projects ranging from discovery route synthesis and process scouting, before project managing a prodrug program. Tom then spent 4.5 years as part of the commercial team Cresset, supporting customers’ access to computational chemistry software and services.

Speaker Name 4

Speaker Title 4
Speaker Company 4

Enter Text Here

Speaker Name 5

Speaker Title 5
Speaker Company 5

Enter Text Here